newsfilter
← Latest News
GlobeNewswire·

Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results

-- Interim Phase 2 Vivacity-MG results met primary endpoints, demonstrating nipocalimab was well-tolerated and achieved rapid and durable responses with significant correlation (p<0.0001) between...